BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Rising Popularity of RFID Labels Favors Growth in RFID in Pharmaceutical Market | TMR Insights

  The recent move of the pharmaceutical sector towards enhancing the verification of the legitimacy of drugs and medications has promoted and created new development and growth opportunities in the global RFID in pharmaceutical market.

  November 19, 2021

   · 

  4 min read
• Drug Development

  Connect Biopharma Completes Enrollment of CBP-307 Global Phase 2 Clinical Trial in Moderate-to-Severe Ulcerative Colitis

  Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), today announced that it has completed full enrollment of the phase 2 clinical trial evaluating CBP-307 in adult patients with moderate-to-severe Ulcerative Colitis (UC).

  November 19, 2021

   · 

  6 min read
• Biotech Bay

  Cerus Corporation to Participate in Stephens Annual Investment Conference

  Cerus Corporation (Nasdaq: CERS) today announced that Kevin D. Green, Cerus’ chief financial officer, is scheduled to participate in the Stephens Annual Investment Conference in Nashville, Tenn., on Friday, December 3, 2021 at 2:00 p.m. ET.

  November 19, 2021

   · 

  1 min read
• FDA

  Amneal Receives Approval for Difluprednate Ophthalmic Emulsion

  Amneal Pharmaceuticals, Inc. today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for difluprednate ophthalmic emulsion 0.05%, which is the generic version of Durezol®.

  November 19, 2021

   · 

  6 min read
• Biotech Beach

  Allergan Aesthetics To Present Data From Its Leading Aesthetic Portfolio At The 2021 American Society For Dermatologic Surgery Virtual Meeting

  Allergan Aesthetics, an AbbVie company, (NYSE: ABBV) today announced that it will present six abstracts from its leading portfolio of aesthetic treatments and products at the American Society for Dermatologic Surgery (ASDS) meeting taking place virtually November 19-21, 2021.

  November 19, 2021

   · 

  13 min read
• Biotech Bay

  Tenaya Therapeutics to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference

  Tenaya Therapeutics to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference.

  November 19, 2021

   · 

  1 min read
• Revance to Present Clinical Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Filler Injection Technique at the 2021 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting

  Revance Therapeutics, Inc. today announced two oral presentations and one ePoster at the American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting, November 19-21, 2021.

  November 19, 2021

   · 

  8 min read
• BioForest

  CytoDyn Research Paper on Leronlimab Published in Frontiers in Immunology Journal

  CytoDyn Inc. today announced that its research paper entitled “CCR5 receptor occupancy analysis reveals increased peripheral blood CCR5+CD4+ T cells following treatment with the anti-CCR5 antibody Leronlimab” has been accepted by Frontiers in Immunology.

  November 19, 2021

   · 

  6 min read